SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (AMEX:INO), a late stage developer of oncology and other therapies using electroporation to deliver drugs and nucleic acids, announced today that the Company’s president and CEO, Avtar Dhillon, M.D., will present a corporate overview on Inovio at BIO InvestorForum 2006, Thursday, October 19th, at 12 p.m. PST (3 p.m. EST). The conference will be held in San Francisco, October 17-19, 2006.
